A new type of ADHD treatment
Designed to treat a wide[br-m] range of ADHD symptoms

ADHD isn’t just one set of symptoms—it’s a mix that can look different for everyone. Simtriyo is FDA-approved for adults, teens, and kids 6+.

Simtriyo is not recommended for children younger than 6 or weighing less than 20 kg due to risk of weight loss.

green
interior
custom
32
custom
40
true
Results for adults
adults
Results for kids 6+ and teens
kids
custom
31
custom
64
false

Simtriyo was proven to reduce symptoms of [br-d] inattention, hyperactivity, and impulsivity

h1
center
text-brand-navy
font-weight-extrabold
What this means for adults with ADHD
eyebrow-color-orange
24
31
24
false
Proven in clinical trials at 6 weeks, Simtriyo was shown to improve:
text-center
text-brand-navy
font-weight-medium
size-medium
link-color-orange
24
31
0
false
Inattention
Hyperactivity
Impulsivity
834px
20px
16px
true
center
In clinical trials, some people saw their symptoms improve in as little as 1 week. Symptom improvement at 1 week was not the main goal of the studies and does not carry the same weight as the main goals of the [br-m] studies.
custom
#F5F3ED
#002c3e
-1
center
How Simtriyo was studied in adults: Two identical studies looked at how Simtriyo worked over 6 weeks for adults aged 18 to 55. In both studies, adult patients took either a low dose,[br-m] high dose, or placebo (no dose) of treatment to measure the change in ADHD symptoms over the course of [br-m] the trial.
custom
#F5F3ED
#002c3e
-1
custom
57
48
false
If these symptoms are still affecting your day-to-day life, talk to your doctor about what you’re experiencing.
#fff
1060px
48
48
custom
64
false
48
68
custom
40
false
custom
52
custom
39
false
custom
31
custom
64
false

Simtriyo was proven to reduce symptoms of [br-d] inattention, hyperactivity, and impulsivity

h1
center
text-brand-navy
font-weight-extrabold
What this means for kids 6+ and teens with ADHD
eyebrow-color-orange
24
31
24
false
Proven in clinical trials at 6 weeks, Simtriyo was shown to improve:
text-center
text-brand-navy
font-weight-medium
size-medium
link-color-orange
24
31
0
false
Inattention
Hyperactivity
Impulsivity
834px
20px
16px
true
center
In clinical trials, some kids and teens saw their symptoms improve in as little as 1 week. Symptom improvement at 1 week was not the main goal of the studies and does not carry the same weight as the main goals of the studies.
custom
#F5F3ED
#002c3e
-1
center
How Simtriyo was studied in kids 6+ and teens: Two age-based studies in kids and teens looked at how Simtriyo worked over 6 weeks to change ADHD symptoms and behaviors. Kids (aged [br-m] 6-12) took a weight-based dose or placebo. Teens (aged 13-17) took either a high or low dose [br-m] of Simtriyo, or placebo.*
custom
#F5F3ED
#002c3e
-1
wider-content-body
custom
30
custom
22
false
*The low dose of Simtriyo studied in teens did not demonstrate changes in ADHD symptoms and behaviors compared to placebo after week 6 in the study and is not an approved dose for teens.
text-center
text-brand-navy
font-weight-medium
size-caption
link-color-orange
755px
custom
57
custom
40
false
If these symptoms are still affecting your child’s day-to-day life, talk to their doctor about what you’re [br-m] noticing.
#fff
1060px
48
48
72
false
48
68
custom
50
false
custom
52
custom
42
false
custom
68
custom
51
false
#002c3e
white
bottom left
734px
h3
Simtriyo is designed to [br-m] support more of the ADHD [br-m] experience
Curious about side effects?
See the safety results
-2
Keep up with the latest on Simtriyo
Stay informed
-2
custom
30
0
0
/content/simtriyo/con/websites/com/efficacy/faq
custom
38.63636363636363% 59.09090909090909%
1
custom
20px
custom
40px
stretch
1060px / 100%/ 100%
center
false
custom
40
8